These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2068275)
1. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines. Cowan DS; Panicucci R; McClelland RA; Rauth AM Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities. Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971 [TBL] [Abstract][Full Text] [Related]
3. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation. Buchko GW; Weinfeld M Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307 [TBL] [Abstract][Full Text] [Related]
4. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin. Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation. Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693 [TBL] [Abstract][Full Text] [Related]
6. DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies. Cowan DS; Matejovic JF; McClelland RA; Rauth AM Br J Cancer; 1994 Dec; 70(6):1067-74. PubMed ID: 7981056 [TBL] [Abstract][Full Text] [Related]
7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1. Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin. Cowan DS; McClelland RA; Rauth AM Biochem Pharmacol; 1995 Jun; 50(1):61-8. PubMed ID: 7605346 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers. Papadopoulou MV; Rosenzweig HS; Bloomer WD Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395 [TBL] [Abstract][Full Text] [Related]
10. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro. Skov KA; Farrell NP; Adomat H Radiat Res; 1987 Nov; 112(2):273-82. PubMed ID: 3685256 [TBL] [Abstract][Full Text] [Related]
11. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Cowan DS; Hicks KO; Wilson WR Br J Cancer Suppl; 1996 Jul; 27():S28-31. PubMed ID: 8763841 [TBL] [Abstract][Full Text] [Related]
12. The phenanthridine biguanides efficiently differentiate between dGdC, dAdT and rArU sequences by two independent, sensitive spectroscopic methods. Radić Stojković M; Miljanić S; Mišković K; Glavaš-Obrovac L; Piantanida I Mol Biosyst; 2011 May; 7(5):1753-65. PubMed ID: 21431121 [TBL] [Abstract][Full Text] [Related]
13. Sequence specificity, enantiospecificity and polyelectrolyte effect in the binding to DNA of a 6-(2-pyridyl)phenanthridine chiral photonuclease. Colmenarejo G; Montero F; Orellana G Anticancer Drug Des; 1997 Jun; 12(4):239-60. PubMed ID: 9199658 [TBL] [Abstract][Full Text] [Related]
14. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II). Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699 [TBL] [Abstract][Full Text] [Related]
15. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443 [TBL] [Abstract][Full Text] [Related]
17. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells. Rockwell S; Irvin CG; Nierenburg M Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554 [TBL] [Abstract][Full Text] [Related]
18. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole. Skov KA; Adomat H; Chaplin DJ; Farrell NP Anticancer Drug Des; 1990 Feb; 5(1):121-8. PubMed ID: 2156514 [TBL] [Abstract][Full Text] [Related]
19. NMR determination of the hetero-association of phenanthridines with daunomycin and their competitive binding to a DNA oligomer. Davies DB; Veselkov DA; Veselkov AN Eur Biophys J; 2002 May; 31(2):153-62. PubMed ID: 12012119 [TBL] [Abstract][Full Text] [Related]
20. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization. Jette DC; Wiebe LI; Flanagan RJ; Lee J; Chapman JD Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]